Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00987649 · ClinicalTrials.gov registry record
Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
A clinical trial, sponsored by Fujirebio Diagnostics.
- Completed
- Registry status
- 512
- Enrollment target
NCT00987649 is a clinical trial that has completed, run by Fujirebio Diagnostics. The registered enrollment target is 512 participants.
The verdict
NCT00987649 has completed, sponsored by Fujirebio Diagnostics.
- COMPLETED
- Registry status
- 512 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the Risk of Ovarian Cancer Algorithm (ROMA) is effective in the determination of a woman's risk of cancer when she is scheduled to have surgery to remove a pelvic mass. After Informed Consent is obtained, an Initial Cancer Risk Assessment will be made. A blood sample will be collected within 30 days of the surgical procedure. Results of the surgical procedure will be collected and analyzed against the CA125 and HE4 results used in the calculation of the ROMA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00987649
The ClinicalTrials.gov registry entry for NCT00987649 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 512 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fujirebio Diagnostics, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00987649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00987649 about?
NCT00987649 is a clinical study titled "Ovarian Cancer Risk Estimation in Patients With Pelvic Mass". The purpose of this study is to determine whether the Risk of Ovarian Cancer Algorithm (ROMA) is effective in the determination of a woman's risk of cancer when she is scheduled to have surgery to remove a pelvic mass. After Informed Consent is obtained, an Initial Cancer Risk Assessment will be ma...
What is the current status of trial NCT00987649?
This trial is currently completed. The enrollment target is 512 participants. The study started on 2009-10. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT00987649?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.